TMDX · TransMedics Group, Inc. · Executive Compensation
Market Cap
$2.85B
Shares
34.68M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $10,915,533 |
| Tamer Khayal | Former Chief Commercial Officer | $3,750,144 |
| Nicholas Corcoran | Senior Vice President of Supply Chain and Operations | $2,819,576 |
| Gerardo Hernandez | Chief Financial Officer | $1,570,572 |
| Anil Ranganath | Former Senior Vice President, General Counsel and Corporate Secretary | $1,503,075 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $8,199,136 |
| Stephen Gordon | Former Chief Financial Officer | $6,764,562 |
| Tamer Khayal | Chief Commercial Officer | $3,077,769 |
| Nicholas Corcoran | Senior Vice President of Supply Chain and Operations | $2,724,567 |
| Gerardo Hernandez | Chief Financial Officer | $1,757,472 |
| Anil Ranganath | Senior Vice President, General Counsel and Corporate Secretary | $594,250 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $6,758,070 |
| Stephen Gordon | Former Chief Financial Officer | $2,640,015 |
| Tamer Khayal | Chief Commercial Officer | $2,630,508 |
| Nicholas Corcoran | Senior Vice President of Supply Chain and Operations | $2,517,432 |
| Nick Corcoran | Senior Vice President of Supply Chain and Operations | $2,517,432 |
| Anil Ranganath | Senior Vice President, General Counsel and Corporate Secretary | $2,187,342 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $3,287,862 |
| Tamer Khayal | Chief Commercial Officer | $1,128,565 |
| Stephen Gordon | Former Chief Financial Officer | $1,124,405 |
| Miriam Provost | Vice President of Global Regulatory Affairs | $813,467 |
| Laura Damme | Vice President, Clinical Affairs | $769,096 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $7,370,365 |
| Tamer Khayal | Chief Commercial Officer | $1,991,552 |
| Stephen Gordon | Chief Financial Officer | $1,969,497 |
| Miriam Provost | Vice President of Global Regulatory Affairs | $953,542 |
| Laura Damme | Vice President, Clinical Affairs | $851,663 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $2,385,687 |
| Tamer Khayal | Chief Commercial Officer | $939,173 |
| Stephen Gordon | Chief Financial Officer | $917,826 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $3,159,298 |
| Tamer Khayal | Chief Commercial Officer | $1,051,372 |
| Stephen Gordon | Chief Financial Officer | $491,923 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Waleed Hassanein | President and Chief Executive Officer | $524,000 |
| Tamer Khayal | Chief Commercial Officer | $415,800 |
| Stephen Gordon | Chief Financial Officer | $371,250 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Fernando Araujo | Chief Financial Officer and Treasurer | Appointed | 2026-09-10 |
| Tamer Khayal, M.D. | Senior Vice President of International | Appointed | 2026-02-04 |
| Giovanni Cecere | Chief Commercial Officer | Appointed | 2026-02-04 |
| Gerardo Hernandez | Chief Financial Officer and Treasurer | Appointed | 2024-12-02 |
Key facts
CIK
1756262
CUSIP
89377M109
13F (30d)
13 filings
12 filers
Visit website
Investor relations